This market expert warns real estate woes may not be limited to commercial — 3 'idiosyncratic' stocks he likes
Yahoo Finance · 2 days ago
Open | 145.38 |
High | 147.33 |
Low | 144.49 |
Mkt Cap | 13.83B |
P/E (TTM) | 348.45 |
Div & Yield | N/A & N/A |
Prev. Close | 145.61 |
52 Wk. Low | 55.25 |
52 Wk. High | 173.25 |
Related stocks
Biopharmaceutical company
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 413.46M | 63.10% ▲ |
Net Income | 36.12M | - |
Diluted EPS | 0.37 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.02 | - |
Q1 2024 | -$0.07 | $0.37 |
Q4 2023 | $0.01 | $0.47 |
S&P FuturesES=F | 5,613.75+3.00 (+0.05%) |
Dow FuturesYM=F | 40,737.00+44.00 (+0.11%) |
Nasdaq FuturesNQ=F | 19,993.25-7.75 (-0.04%) |
5.01+627.35% | |
Alphabet Inc.GOOG | 183.35+2.21% |
283.81+5.39% |